Axumin Pet Scan Radiology

Axumin imaging center directory.

Axumin pet scan radiology. Locate a facility near you. Axumin fluciclovine f 18 is an advanced diagnostic imaging agent or radiotracer that is used with a positron emission tomography pet computed tomography ct scan for men who have had prior treatment for prostate cancer and now have elevated prostate specific antigen psa levels. American college of radiology acr appropriateness criteria. Little renal excretion ovals is seen and the activity in the bladder b is mild.

Axumin a radioactive imaging agent that binds itself to prostate cancer cells is injected before a pet scan in patients whose prostate cancer may have returned after treatment. If you re a healthcare provider and are not able to find a local imaging site or have other questions about a specific imaging center please contact siemens healthineers petnet solutions customer care at 877 473 8638. As with spect imaging pet scan data can be reconstructed and displayed as a three dimensional image. 3 2016 blue earth diagnostics inc.

Conventional ct and nuclear medicine bone scans have limited sensitivity especially in patients with low psa levels less than 10 ng ml. Axumin fluciclovine f 18 injection is indicated for positron emission tomography pet imaging in men with suspected prostate cancer recurrence based on. The axumin scan is done within an hour with less radiation and significantly greater image resolution. Axumin fluciclovine f 18 injection is indicated for positron emission tomography pet imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen psa levels following prior treatment.

Coronal caudal to cranial pet scan acquired 4 minutes after the injection of facbc shows the normal distribution of the radiotracer. The axumin scan utilizes positron emission tomography with computed tomography also called pet ct a nuclear medicine imaging tool that can pinpoint metabolic activity within the body. View real world case studies. It involves the intravenous injection of a positron emitting radiopharmaceutical waiting to allow for systemic distribution and then scanning for detection and quantification of patterns of radiopharmaceutical accumulation in the body.

Axumin is indicated for positron emission tomography pet imaging in men with suspected prostate cancer recurrence based on elevated psa levels following prior treatment. Consider the potential clinical impact of axumin scans. With information provided by the scan physicians can treat both the prostate and other affected areas more.